1. Home
  2. AVXL vs SBSI Comparison

AVXL vs SBSI Comparison

Compare AVXL & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • SBSI
  • Stock Information
  • Founded
  • AVXL 2004
  • SBSI 1960
  • Country
  • AVXL United States
  • SBSI United States
  • Employees
  • AVXL N/A
  • SBSI N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • SBSI Major Banks
  • Sector
  • AVXL Health Care
  • SBSI Finance
  • Exchange
  • AVXL Nasdaq
  • SBSI Nasdaq
  • Market Cap
  • AVXL 956.7M
  • SBSI 920.2M
  • IPO Year
  • AVXL N/A
  • SBSI N/A
  • Fundamental
  • Price
  • AVXL $9.95
  • SBSI $30.09
  • Analyst Decision
  • AVXL Strong Buy
  • SBSI Hold
  • Analyst Count
  • AVXL 2
  • SBSI 3
  • Target Price
  • AVXL $44.00
  • SBSI $35.00
  • AVG Volume (30 Days)
  • AVXL 1.2M
  • SBSI 109.7K
  • Earning Date
  • AVXL 08-12-2025
  • SBSI 07-25-2025
  • Dividend Yield
  • AVXL N/A
  • SBSI 4.71%
  • EPS Growth
  • AVXL N/A
  • SBSI 4.30
  • EPS
  • AVXL N/A
  • SBSI 2.81
  • Revenue
  • AVXL N/A
  • SBSI $254,956,000.00
  • Revenue This Year
  • AVXL N/A
  • SBSI $10.88
  • Revenue Next Year
  • AVXL N/A
  • SBSI $5.60
  • P/E Ratio
  • AVXL N/A
  • SBSI $10.88
  • Revenue Growth
  • AVXL N/A
  • SBSI 6.01
  • 52 Week Low
  • AVXL $4.93
  • SBSI $25.85
  • 52 Week High
  • AVXL $14.44
  • SBSI $38.00
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 39.87
  • SBSI 52.87
  • Support Level
  • AVXL $9.90
  • SBSI $28.11
  • Resistance Level
  • AVXL $11.70
  • SBSI $30.72
  • Average True Range (ATR)
  • AVXL 0.70
  • SBSI 0.58
  • MACD
  • AVXL -0.23
  • SBSI 0.10
  • Stochastic Oscillator
  • AVXL 1.62
  • SBSI 68.58

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About SBSI Southside Bancshares Inc.

Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.

Share on Social Networks: